E
ZYUS Life Sciences Corporation ZYUS.V
TSX
Recommendation
Prev Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -50.28% -32.93% -66.68% -66.03% 11.17%
Total Depreciation and Amortization 41.89% 22.97% -3.15% -3.99% -36.65%
Total Amortization of Deferred Charges -- -- -- -- -27.38%
Total Other Non-Cash Items 99.25% 53.98% 140.30% 203.01% 17.28%
Change in Net Operating Assets 193.93% -200.57% -380.19% -277.18% -366.65%
Cash from Operations 56.97% -37.20% -123.11% -80.92% -47.50%
Capital Expenditure 34.19% 37.35% 54.16% 51.22% 59.41%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -100.00% -100.00% 15,622.03% 15,622.03% --
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -105.17% -105.77% 865.02% 870.74% 616.94%
Total Debt Issued -97.03% -98.45% 91.26% 116.85% 136.16%
Total Debt Repaid 14.53% 63.18% -1,178.43% -1,096.79% -12,178.13%
Issuance of Common Stock -- -- -- -- -100.00%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -96.74% -104.09% 49.30% 71.79% 83.84%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -196.71% -196.06% -84.73% 763.18% 512.09%
Weiss Ratings